Work

High SVR Rates Among US Patients Regardless of Race or Ethnicity in HCV GT1 Patients Receiving the Label-Recommended Regimen of Ombitasvir/Paritaprevir/r+Dasabuvir±Ribavirin: Integrated Safety and Efficacy Analysis

Year: 2015

Type: article

Source: The American Journal of Gastroenterology

DOI: 10.14309/00000434-201510001-02038

Authors: Nancy Reau, Andrew J. Muir, Paul Pockros, Rajender K. Reddy, Marcos Pedrosa, Lois Larsen, Jeffrey Enejosa, Charles Howell

Institutions: University of Chicago Medical Center, Duke University, Duke Medical Center, Scripps Clinic, University of Pennsylvania, AbbVie (United States), Howard University Hospital

Language: English

Topic: Hepatitis C virus research

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2978262089

FWCI:

Cites:

Cited by:

Related to: 10